Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Lung Neoplasms and Erbb4[original query] |
---|
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. PloS one 2007 2 (5): e426. Marks Jenifer L, McLellan Michael D, Zakowski Maureen F, Lash Alex E, Kasai Yumi, Broderick Stephen, Sarkaria Inderpal S, Pham Duykhanh, Singh Bhuvanesh, Miner Tracie L, Fewell Ginger A, Fulton Lucinda L, Mardis Elaine R, Wilson Richard K, Kris Mark G, Rusch Valerie W, Varmus Harold, Pao Willi |
Analysis of ERBB4 mutations and expression in japanese patients with lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Nov 5 (11): 1859-61. Tomizawa Kenji, Suda Kenichi, Onozato Ryoichi, Kuwano Hiroyuki, Yatabe Yasushi, Mitsudomi Tetsu |
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Nov 5 (11): 1734-40. Lee Shin Yup, Kim Min Jung, Jin Guang, Yoo Seung Soo, Park Ji Young, Choi Jin Eun, Jeon Hyo Sung, Cho Sukki, Lee Eung Bae, Cha Seung Ick, Park Tae-In, Kim Chang Ho, Jung Tae Hoon, Park Jae Yo |
Hot spot mutations in Finnish non-small cell lung cancers. Lung cancer (Amsterdam, Netherlands) 2016 Sep 99 102-10. Mäki-Nevala Satu, Sarhadi Virinder Kaur, Rönty Mikko, Kettunen Eeva, Husgafvel-Pursiainen Kirsti, Wolff Henrik, Knuuttila Aija, Knuutila Saka |
Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jul 28 (7): 1625-1630. Zhang Y, Zhang L, Li R, Chang D W, Ye Y, Minna J D, Roth J A, Han B, Wu |
Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment. Oncotarget 2018 May 9 (40): 26195-26208. Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Grauslund Morten, Melchior Linea, Sørensen Jens Be |
About molecular profile of lung cancer in Tunisian patients. Journal of immunoassay & immunochemistry 2018 39 (1): 99-107. Mezni Faouzi, Mlika Mona, Boussen Hamouda, Ghedira Habib, Fenniche Soraya, Faten Talmoudi, Loriot Marie-An |
Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease markers 2019 2019 3837687. Kang Jingjing, Luo Yang, Wang Di, Men Yu, Wang Jianyang, Che Yi-Qun, Hui Zhougua |
PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh |
Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study. Medicine 2021 May 100 (19): e25762. Wang Wan-Ping, Bian Hai-Bo, Wang Xia-Zhen, Liu Liang, Wei Di |
Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs. Frontiers in oncology 2021 4 11 643199. Ma Li, Li Haoyang, Wang Dongpo, Hu Ying, Yu Mengjun, Zhang Quan, Qin Na, Zhang Xinyong, Li Xi, Zhang Hui, Wu Yuhua, Lv Jialin, Yang Xinjie, Yu Ruoying, Zhang Shucai, Wang Jingh |
Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study. Lung cancer (Amsterdam, Netherlands) 2021 12 163 7-13. Tan D S-W, Thomas M, Kim D-W, Szpakowski S, Urban P, Mehra R, Chow L Q M, Sharma S, Solomon B J, Felip E, Camidge D R, Vansteenkiste J, Petruzzelli L, Pantano S, Shaw A |
The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Molecular medicine (Cambridge, Mass.) 2021 Oct 27 (1): 126. Hu Xilin, Xu Hanlin, Xue Qianwen, Wen Ruran, Jiao Wenjie, Tian Kaih |
Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. Translational cancer research 2022 May 11 (5): 1245-1254. Zhang Meichun, Wu Jing, Zhong Weinong, Zhao Ziwen, Guo Weiho |
Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes. Journal of personalized medicine 2022 3 12 (3): . Pop-Bica Cecilia, Ciocan Cristina Alexandra, Braicu Cornelia, Harangu? Antonia, Simon Marioara, Nutu Andreea, Pop Laura Ancuta, Slaby Ondrej, Atanasov Atanas G, Pirlog Radu, Al Hajjar Nadim, Berindan-Neagoe Ioa |
Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer genomics & proteomics 2023 8 20 (5): 417-432. Yaroslav Ilnytskyy, Lars Petersen, John B McIntyre, Mie Konno, Adrijana D'Silva, Michelle Dean, Anifat Elegbede, Andrey Golubov, Olga Kovalchuk, Igor Kovalchuk, Gwyn Be |
- Page last reviewed:Feb 1, 2024
- Content source: